$Oragenics (OGEN.US)$ On Thursday, Oragenics Inc. (NYSE:OGEN...
$Oragenics (OGEN.US)$ On Thursday, Oragenics Inc. (NYSE:OGEN) announced that its lead candidate for treating concussion completed a study that indicates ONP-002 does not cause cardiotoxicity.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment